Gotowe bibliografie tematyczne / Treenut allergy / Artykuły w czasopismach
Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Treenut allergy.

Artykuły w czasopismach na temat „Treenut allergy”

Autor: Grafiati
Data publikacji: 2 czerwca 2025
Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 17 najlepszych artykułów w czasopismach naukowych na temat „Treenut allergy”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Goldberg, Michael R., Michael Y. Appel, Liat Nachshon, Mor Carmel, Michael B. Levy, and Arnon Elizur. "The Utility of BAT in Diagnosing Treenut Allergy." Journal of Allergy and Clinical Immunology 139, no. 2 (2017): AB276. http://dx.doi.org/10.1016/j.jaci.2016.12.887.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Shen, Jerry, Annaliesse Blincoe, Jenny Heyward, and Kuang-Chih Hsiao. "Factors associated with continued peanut, treenut and sesame ingestion post successful oral food challenge." Journal of Allergy and Clinical Immunology 149, no. 2 (2022): AB103. http://dx.doi.org/10.1016/j.jaci.2021.12.358.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Wood, Robert A. "Clinical Features of Acute Allergic Reactions to Peanut and TreeNuts in Children." Pediatrics 104, Supplement_2 (1999): 364. http://dx.doi.org/10.1542/peds.104.s2.364a.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

CLARK, A., Y. KING, and P. EWAN. "The Clinical Features of Accidental Reactions to Peanuts and Treenuts After Diagnois in Children." Journal of Allergy and Clinical Immunology 121, no. 2 (2008): S253. http://dx.doi.org/10.1016/j.jaci.2007.12.1003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Hirano, Ikuo, Marc Rothenberg, Evan Dellon, et al. "Dupilumab suppresses type 2 biomarkers of inflammation in patients with eosinophilic esophagitis: from Part B of LIBERTY-EoE-TREET." Journal of Allergy and Clinical Immunology 151, no. 2 (2023): AB199. http://dx.doi.org/10.1016/j.jaci.2022.12.623.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Rothenberg, Marc, Jonathan Spergel, Evan Dellon, et al. "Patients with eosinophilic esophagitis have a high baseline burden of atopic/allergic comorbidities: from Parts A and B of LIBERTY-EoE-TREET." Journal of Allergy and Clinical Immunology 151, no. 2 (2023): AB88. http://dx.doi.org/10.1016/j.jaci.2022.12.279.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Dellon, E., M. Rothenberg, I. Hirano, et al. "DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, ENDOSCOPIC ASPECTS OF EOE: POOLED RESULTS FROM PHASE 3 LIBERTY-EOE-TREET." Annals of Allergy, Asthma & Immunology 129, no. 5 (2022): S25—S34. http://dx.doi.org/10.1016/j.anai.2022.08.603.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Spergel, Jonathan, Lawrence Sher, Sandy Durrani, et al. "Dupilumab improves type 2 comorbidity outcomes in patients with eosinophilic esophagitis and comorbid disease at baseline: from Parts A and B of LIBERTY-EoE-TREET." Journal of Allergy and Clinical Immunology 151, no. 2 (2023): AB199. http://dx.doi.org/10.1016/j.jaci.2022.12.622.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Rothenberg, Marc, Ikuo Hirano, Evan Dellon, et al. "Dupilumab Reduces Biomarkers of Type 2 Inflammation in Adult and Adolescent Patients With Eosinophilic Esophagitis: Results From Parts A and C of a Three-Part, Phase 3 LIBERTY EoE TREET Study." Journal of Allergy and Clinical Immunology 149, no. 2 (2022): AB210. http://dx.doi.org/10.1016/j.jaci.2021.12.688.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Rothenberg, Marc, Evan Dellon, Albert Bredenoord, et al. "Dupilumab Improves Clinical and Histologic Aspects of Disease in Adult and Adolescent Patients With Eosinophilic Esophagitis at Week 24: Results from Part B of the 3-Part LIBERTY EoE TREET Study." Journal of Allergy and Clinical Immunology 149, no. 2 (2022): AB312. http://dx.doi.org/10.1016/j.jaci.2021.12.003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Dellon, E. S., M. E. Rothenberg, M. H. Collins, et al. "Dupilumab safety and efficacy up to 52 weeks in adult and adolescent patients with eosinophilic esophagitis: Results from part A and C of a randomized, placebo-controlled, three-part, phase 3 LIBERTY EoE TREET Study." Revue Française d'Allergologie 62, no. 3 (2022): 372. http://dx.doi.org/10.1016/j.reval.2022.02.199.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Dellon, E. S., M. E. Rothenberg, M. H. Collins, et al. "Dupilumab efficacy and safety up to 52 weeks in adult and adolescent patients with eosinophilic esophagitis: Results from parts B and C of the randomized, placebo-controlled, three-part, phase 3 LIBERTY EoE TREET Study." Revue Française d'Allergologie 63, no. 3 (2023): 103594. http://dx.doi.org/10.1016/j.reval.2023.103594.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Zirwas, Matthew, Raj Chovatiya, Linda Stein Gold, et al. "564 - Conjunctivitis adverse events in dupilumab clinical trials." British Journal of Dermatology 190, Supplement_2 (2024): ii58—ii59. http://dx.doi.org/10.1093/bjd/ljad498.060.

Pełny tekst źródła
Streszczenie:
Abstract Introduction Dupilumab inhibits signaling of IL-4 and IL-13, key drivers of Type 2 inflammatory diseases such as atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), eosinophilic esophagitis (EoE), prurigo nodularis (PN), and Chronic Spontaneous Urticaria (CSU).1,2 Adults with AD have a significant and disease severity-dependent increased risk of developing ocular surface diseases, including conjunctivitis and keratitis, compared with the general population.3 In randomized placebo-controlled trials of dupilumab in patients with moderate-to-severe AD, m
Style APA, Harvard, Vancouver, ISO itp.
14

Ta, Von, Brittany Weldon, Grace Yu, Olivier Humblet, Susan Neale-May, and Kari Nadeau. "Use of Specific IgE and Skin Prick Test to Determine Clinical Reaction Severity." September 9, 2011. https://doi.org/10.5281/zenodo.7803.

Pełny tekst źródła
Streszczenie:
Aims: To determine whether specific IgE and skin prick test correlate better in predicting reaction severity during a double-blinded placebo controlled food challenge (DBPCFC) for egg, milk, and multiple tree nut allergens. Study design: Prospective study. Place and Duration of Study: Department of Pediatrics, Stanford University School of Medicine, August 2009 and ongoing. Methodology: We examined the reaction severity of twenty-four subjects to nine possible food allergens: milk, egg, almond, cashew, hazelnut, peanut, sesame, pecan and walnut. Specific IgE and SPT were performed before each
Style APA, Harvard, Vancouver, ISO itp.
15

Ta, Von, Brittany Weldon, Grace Yu, Olivier Humblet, Susan Neale-May, and Kari Nadeau. "Use of Specific IgE and Skin Prick Test to Determine Clinical Reaction Severity." September 9, 2011. https://doi.org/10.5281/zenodo.7784.

Pełny tekst źródła
Streszczenie:
Aims: To determine whether specific IgE and skin prick test correlate better in predicting reaction severity during a double-blinded placebo controlled food challenge (DBPCFC) for egg, milk, and multiple tree nut allergens. Study design: Prospective study. Place and Duration of Study: Department of Pediatrics, Stanford University School of Medicine, August 2009 and ongoing. Methodology: We examined the reaction severity of twenty-four subjects to nine possible food allergens: milk, egg, almond, cashew, hazelnut, peanut, sesame, pecan and walnut. Specific IgE and SPT were performed before each
Style APA, Harvard, Vancouver, ISO itp.
16

McWilliam, Vicki L., Jennifer J. Koplin, Katie Allen, et al. "TreEAT trial: Protocol for a randomized controlled trial investigating the efficacy and safety of early introduction of tree nuts for the prevention of tree nut allergy in infants with peanut allergy." Pediatric Allergy and Immunology 34, no. 3 (2023). http://dx.doi.org/10.1111/pai.13930.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

"P29: TREEAT TRIAL: PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF EARLY INTRODUCTION OF TREE NUTS FOR THE PREVENTION OF TREE NUT ALLERGY IN INFANTS WITH PEANUT ALLERGY." Internal Medicine Journal 52, S5 (2022): 12. http://dx.doi.org/10.1111/imj.28_15894.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii